CounterPath Story

<div class='circular--portrait' style='background:#689CFD;color: #ffffff;font-size:4em;'>CO</div>
CPAH -- USA Stock  

USD 3.38  0.02  0.59%

It looks like DATATRAK INTERNATIONAL will be up for a correction way faster as its share price whent up 11.11% today to CounterPath's 1.1696%. As many baby boomers are still indifferent towards technology space, we will concentrate on both CounterPath as well as DATATRAK INTERNATIONAL INC. We are going to examine some of the competitive aspects of both CounterPath and DATATRAK.
Published over a month ago
View all stories for CounterPath | View All Stories
Will CounterPath (NASDAQ:CPAH) stockholders shift to DATATRAK (OTC:DTRK)?
By analyzing existing basic indicators between CounterPath and DATATRAK, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in DATATRAK with a short position in CounterPath. Check out our pair correlation module for more information.

Let's begin by analyzing the assets. The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CounterPath has an asset utilization ratio of 99.95 percent. This implies that the company is making $1.0 for each dollar of assets. An increasing asset utilization means that CounterPath is more efficient with each dollar of assets it utilizes for everyday operations.
Out of tens of thousands of stocks, funds, and ETFs that trade on global exchanges each represent an individual company which you can analyze using comparative analysis. To determine which one of the two companies, such as CounterPath or DATATRAK is a better fit for your portfolio, analyzing a few basic fundamental indicators is a good first step.

How important is CounterPath's Liquidity

CounterPath financial leverage refers to using borrowed capital as a funding source to finance CounterPath ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. CounterPath financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between CounterPath's total debt and its cash.

Correlation Between CounterPath and DATATRAK INTERNATIONAL

In general, stock analysis is a method for investors and traders to make individual buying and selling decisions. Stock correlation analysis is also essential because it can help investors realize that they may not be as diversified as they think. Risk management strategies are usually required to make sure all portfolios are properly aligned against their risk tolerance level. You can consider holding CounterPath together with similar or unrelated positions with a negative correlation. For example, you can also add DATATRAK INTERNATIONAL to your portfolio. If DATATRAK INTERNATIONAL is not perfectly correlated to CounterPath it will diversify some of the market risks out of the positively correlated stocks in your portfolio. However, the disadvantage of this sort of hedging is that it can potentially affect your investment returns throughout market cycles. When CounterPath for example, for example, performs excellent and delivers stable returns, the negatively correlated position you locked in as a hedge may drag your returns down. Please check pair correlation details between CPAH and DTRK for more information.

CounterPath exotic insider transaction detected

Legal trades by CounterPath insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
CounterPath insider trading alert for general transaction of deferred share units by Todd Carothers, Chief Revenue Officer, on 9th of December 2020. This event was filed by Counterpath Corp with SEC on 2020-12-09. Statement of changes in beneficial ownership - SEC Form 4. Todd Carothers currently serves as executive vice president of sales and marketing of CounterPath [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Detailed Perspective On CounterPath

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Now, let's check CounterPath revenue. Based on the latest financial disclosure, CounterPath reported 12.96 M of revenue. This is 99.68% lower than that of the Technology sector and significantly higher than that of the Software?Application industry. The revenue for all United States stocks is 99.86% higher than that of CounterPath. As for DATATRAK INTERNATIONAL we see revenue of 7.36 M, which is much higher than that of the Software?Application

CounterPath12.96 Million
DATATRAK7.36 Million
13 M
7.4 M

CounterPath may start a bounce back in January

Current kurtosis is at 9.94. CounterPath exhibits very low volatility with skewness of 1.09 and kurtosis of 9.94. However, we advise investors to further study CounterPath technical indicators to make sure all market info is available and is reliable.

Our Takeaway on CounterPath Investment

While some other entities under the software?application industry are still a bit expensive, CounterPath may offer a potential longer-term growth to stockholders. While some stockholders may not share our view we believe that the current risk-reward utility is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to CounterPath.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of CounterPath. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to